A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical

Authors

Jaime Simón, IsoTherapeutics Group, LLC
R. Keith Frank, IsoTherapeutics Group, LLC
Druce K. Crump, IsoTherapeutics Group, LLC
William D. Erwin, The University of Texas MD Anderson Cancer Center
Naoto T. Ueno, The University of Texas MD Anderson Cancer Center
Richard E. Wendt PHD, University of MD Anderson Cancer CenterFollow

Files

Description

Simón J, Frank RK, Crump DK, Erwin WD, Ueno NT, Wendt RE. A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical. Nuclear Medicine and Biology. 2012/08/01/ 2012;39(6):770-776. doi:https://doi.org/10.1016/j.nucmedbio.2011.12.015

DOI

https://doi.org/10.1016/j.nucmedbio.2011.12.015

Publication Date

8-2012

Publisher

Elsevier ScienceDirect

Keywords

153Sm-DOTMPBone-seeking radiopharmaceuticalPreclinical study

Recommended Citation

Simón, Jaime; Frank, R. Keith; Crump, Druce K.; Erwin, William D.; Ueno, Naoto T.; and Wendt, Richard E. PHD, "A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical" (2012). Imaging Physics Journal Articles. 7.
doi:https://doi.org/10.1016/j.nucmedbio.2011.12.015